2021-01-12," <Research Report>M Stanley's Latest Ratings, TPs on CN Drugmakers (Table)  "
2021-01-05,   《HKEx》- 02186 LUYE PHARMA - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020 
2020-12-28, *M Stanley Upgrades LUYE PHARMA (02186.HK) to Equalweight with TP Added to $3.8  
2020-12-15,   《HKEx》- 02186 LUYE PHARMA - DISCLOSEABLE TRANSACTION - THIRD PARTIES'' INVESTMENTS IN SHANDONG BOAN 
2020-12-15,   《HKEx》- 02186 LUYE PHARMA - VOLUNTARY ANNOUNCEMENT - LY03009 COMMENCED PHASE I CLINICAL TRIAL IN AUSTRALIA 
2020-12-15,   《HKEx》- 02186 LUYE PHARMA - ANNOUNCEMENT - INCLUSION OF LIPUSU IN THE NEW CATALOGUE OF NATIONAL REIMBURSEMENT DRUG LIST 
